vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $135.5M, roughly 2.0× Sezzle Inc.). Sezzle Inc. runs the higher net margin — 37.9% vs 0.7%, a 37.1% gap on every dollar of revenue. On growth, Sezzle Inc. posted the faster year-over-year revenue change (29.2% vs -16.5%).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.

HCM vs SEZL — Head-to-Head

Bigger by revenue
HCM
HCM
2.0× larger
HCM
$270.8M
$135.5M
SEZL
Growing faster (revenue YoY)
SEZL
SEZL
+45.7% gap
SEZL
29.2%
-16.5%
HCM
Higher net margin
SEZL
SEZL
37.1% more per $
SEZL
37.9%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
SEZL
SEZL
Revenue
$270.8M
$135.5M
Net Profit
$2.0M
$51.3M
Gross Margin
37.7%
Operating Margin
-13.2%
50.9%
Net Margin
0.7%
37.9%
Revenue YoY
-16.5%
29.2%
Net Profit YoY
-83.6%
41.9%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SEZL
SEZL
Q1 26
$135.5M
Q4 25
$270.8M
$78.2M
Q3 25
$57.5M
Q2 25
$277.7M
$52.0M
Q1 25
$324.5M
$48.2M
Q4 24
$48.4M
Q3 24
$35.6M
Q2 24
$305.7M
$30.2M
Net Profit
HCM
HCM
SEZL
SEZL
Q1 26
$51.3M
Q4 25
$2.0M
$42.7M
Q3 25
$26.7M
Q2 25
$455.0M
$27.6M
Q1 25
$11.9M
$36.2M
Q4 24
$25.4M
Q3 24
$15.4M
Q2 24
$25.8M
$29.7M
Gross Margin
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
SEZL
SEZL
Q1 26
50.9%
Q4 25
-13.2%
70.6%
Q3 25
61.9%
Q2 25
-1.3%
69.4%
Q1 25
-5.0%
Q4 24
63.8%
Q3 24
58.6%
Q2 24
-9.0%
55.3%
Net Margin
HCM
HCM
SEZL
SEZL
Q1 26
37.9%
Q4 25
0.7%
54.6%
Q3 25
46.4%
Q2 25
163.8%
53.1%
Q1 25
3.7%
75.1%
Q4 24
52.4%
Q3 24
43.4%
Q2 24
8.4%
98.4%
EPS (diluted)
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
$0.00
$1.19
Q3 25
$0.75
Q2 25
$0.52
$0.78
Q1 25
$0.01
$1.00
Q4 24
$0.71
Q3 24
$0.44
Q2 24
$0.03
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SEZL
SEZL
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$196.7M
Total Assets
$1.8B
$454.3M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
$1.4B
$64.1M
Q3 25
$104.1M
Q2 25
$1.4B
$88.9M
Q1 25
$836.1M
$88.9M
Q4 24
$73.2M
Q3 24
$80.1M
Q2 24
$802.5M
$58.0M
Total Debt
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
SEZL
SEZL
Q1 26
$196.7M
Q4 25
$1.2B
$169.8M
Q3 25
$155.3M
Q2 25
$1.2B
$130.4M
Q1 25
$759.9M
$125.8M
Q4 24
$87.8M
Q3 24
$61.1M
Q2 24
$740.1M
$50.3M
Total Assets
HCM
HCM
SEZL
SEZL
Q1 26
$454.3M
Q4 25
$1.8B
$400.2M
Q3 25
$367.0M
Q2 25
$1.8B
$350.6M
Q1 25
$1.3B
$298.1M
Q4 24
$298.4M
Q3 24
$252.9M
Q2 24
$1.3B
$212.1M
Debt / Equity
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SEZL
SEZL
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
$8.2M
$70.6M
Q3 25
$63.7M
Q2 25
$-72.9M
$23.1M
Q1 25
$40.3M
$52.5M
Q4 24
$57.4M
Q3 24
$35.1M
Q2 24
$-39.8M
$22.2M
Free Cash Flow
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
$3.4M
$70.6M
Q3 25
$63.6M
Q2 25
$-82.2M
$22.7M
Q1 25
$32.5M
$52.5M
Q4 24
$57.4M
Q3 24
$35.1M
Q2 24
$-49.9M
$22.2M
FCF Margin
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
1.2%
90.2%
Q3 25
110.6%
Q2 25
-29.6%
43.6%
Q1 25
10.0%
108.9%
Q4 24
118.5%
Q3 24
98.6%
Q2 24
-16.3%
73.4%
Capex Intensity
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
1.8%
0.1%
Q3 25
0.3%
Q2 25
3.3%
0.8%
Q1 25
2.4%
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
3.3%
0.1%
Cash Conversion
HCM
HCM
SEZL
SEZL
Q1 26
Q4 25
4.21×
1.65×
Q3 25
2.39×
Q2 25
-0.16×
0.84×
Q1 25
3.38×
1.45×
Q4 24
2.26×
Q3 24
2.27×
Q2 24
-1.54×
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons